FDA grants nivolumab accelerated approval for MSI-H or dMMR colorectal cancer
admin 17th August 2017 Uncategorised 0European Society for Medical Oncology News
More: FDA grants nivolumab accelerated approval for MSI-H or dMMR colorectal cancer
Source: MDlinx